Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

HBV-related Hepatocellular Carcinoma: A Call to Improve Surveillance and Linkage to Care. Liver international : official journal of the International Association for the Study of the Liver Huang, D. Q., Hoang, J. K., Nguyen, M. H. 2021

Abstract

In our recent multi-center study, we found that non-Asians with hepatitis B virus (HBV) related hepatocellular carcinoma (HCC) were more likely to present with decompensated and advanced disease compared with Asians 1 . However, non-Asians were more likely to undergo curative HCC treatment versus Asians. Among patients without cirrhosis, non-Asians had a poorer 5-year survival versus Asians (38% versus 54%). The letter from Dr Jia and colleagues raises some points that merit discussion 2 .

View details for DOI 10.1111/liv.15023

View details for PubMedID 34309185